Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 303

Results For "RI"

11107 News Found

Origin Materials and Minafin form strategic partnership for biobased chemicals
News | February 08, 2022

Origin Materials and Minafin form strategic partnership for biobased chemicals

The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries


Azurity Pharma gets USFDA approval for Fleqsuvy
Drug Approval | February 08, 2022

Azurity Pharma gets USFDA approval for Fleqsuvy

Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%


Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis
Biotech | February 08, 2022

Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis

Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane


Serum receives green light for Omicron variant vaccine
News | February 07, 2022

Serum receives green light for Omicron variant vaccine

Pfizer and Moderna are also working on vaccines that target the Omicron variant


India grants Emergency Use Authorisation to Sputnik Light
News | February 07, 2022

India grants Emergency Use Authorisation to Sputnik Light

This is the ninth Covid-19 vaccine approved in India


Expert panel recommends Emergency Use Authorisation for Sputnik Light
News | February 05, 2022

Expert panel recommends Emergency Use Authorisation for Sputnik Light

The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval


Pristyn Care doubles it surgical centres to 800 in 2021
Startup | February 03, 2022

Pristyn Care doubles it surgical centres to 800 in 2021

Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost


USFDA approves first generic of Restasis
Drug Approval | February 03, 2022

USFDA approves first generic of Restasis

Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug


More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun
interviews | February 02, 2022

More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun

Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health


Lupin signs deal with Axantia to market pegfilgrastim in Middle East and Africa
News | February 01, 2022

Lupin signs deal with Axantia to market pegfilgrastim in Middle East and Africa

Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy